| Product Code: ETC7547720 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India methicillin-resistant Staphylococcus aureus drugs market import shipment experienced a significant decline from 2020 to 2024, with a CAGR of -77.5% during this period. Notably, from 2023 to 2024, the growth rate plummeted by -97.1%, indicating a rapid contraction. The market exhibited a substantial slowdown, showing a downward trend with diminishing momentum.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Methicillin Resistant Staphylococcus Aureus Drugs Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Methicillin Resistant Staphylococcus Aureus Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 India Methicillin Resistant Staphylococcus Aureus Drugs Market - Industry Life Cycle |
3.4 India Methicillin Resistant Staphylococcus Aureus Drugs Market - Porter's Five Forces |
3.5 India Methicillin Resistant Staphylococcus Aureus Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 India Methicillin Resistant Staphylococcus Aureus Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 India Methicillin Resistant Staphylococcus Aureus Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of methicillin-resistant Staphylococcus aureus (MRSA) infections in India |
4.2.2 Growing awareness about the importance of appropriate antibiotic use and infection control measures |
4.2.3 Rising investments in healthcare infrastructure and facilities to combat antibiotic-resistant bacteria |
4.3 Market Restraints |
4.3.1 High cost associated with MRSA drugs and treatment |
4.3.2 Limited availability of effective MRSA drugs in the Indian market |
4.3.3 Challenges in implementing stringent infection control practices in healthcare settings |
5 India Methicillin Resistant Staphylococcus Aureus Drugs Market Trends |
6 India Methicillin Resistant Staphylococcus Aureus Drugs Market, By Types |
6.1 India Methicillin Resistant Staphylococcus Aureus Drugs Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 India Methicillin Resistant Staphylococcus Aureus Drugs Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 India Methicillin Resistant Staphylococcus Aureus Drugs Market Revenues & Volume, By Lipopeptides, 2021- 2031F |
6.1.4 India Methicillin Resistant Staphylococcus Aureus Drugs Market Revenues & Volume, By Oxazolidinones, 2021- 2031F |
6.1.5 India Methicillin Resistant Staphylococcus Aureus Drugs Market Revenues & Volume, By Cephalosporin, 2021- 2031F |
6.1.6 India Methicillin Resistant Staphylococcus Aureus Drugs Market Revenues & Volume, By Tetracycline, 2021- 2031F |
6.1.7 India Methicillin Resistant Staphylococcus Aureus Drugs Market Revenues & Volume, By Folate Antagonist, 2021- 2031F |
6.1.8 India Methicillin Resistant Staphylococcus Aureus Drugs Market Revenues & Volume, By Other, 2021- 2031F |
6.2 India Methicillin Resistant Staphylococcus Aureus Drugs Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 India Methicillin Resistant Staphylococcus Aureus Drugs Market Revenues & Volume, By Oral Administration, 2021- 2031F |
6.2.3 India Methicillin Resistant Staphylococcus Aureus Drugs Market Revenues & Volume, By Parenteral Administration, 2021- 2031F |
7 India Methicillin Resistant Staphylococcus Aureus Drugs Market Import-Export Trade Statistics |
7.1 India Methicillin Resistant Staphylococcus Aureus Drugs Market Export to Major Countries |
7.2 India Methicillin Resistant Staphylococcus Aureus Drugs Market Imports from Major Countries |
8 India Methicillin Resistant Staphylococcus Aureus Drugs Market Key Performance Indicators |
8.1 Rate of MRSA infections in India |
8.2 Adoption rate of guidelines for appropriate antibiotic use and infection control |
8.3 Investment in research and development of new MRSA drugs |
8.4 Number of healthcare facilities with dedicated MRSA management programs |
8.5 Patient adherence to prescribed MRSA treatment regimens |
9 India Methicillin Resistant Staphylococcus Aureus Drugs Market - Opportunity Assessment |
9.1 India Methicillin Resistant Staphylococcus Aureus Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 India Methicillin Resistant Staphylococcus Aureus Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10 India Methicillin Resistant Staphylococcus Aureus Drugs Market - Competitive Landscape |
10.1 India Methicillin Resistant Staphylococcus Aureus Drugs Market Revenue Share, By Companies, 2024 |
10.2 India Methicillin Resistant Staphylococcus Aureus Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here